Global Molecular Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431692
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer AG
  • BioMerieux SA
  • Danaher Corporation
  • F.Hoffman La-Roche Ltd.
  • MORE
Molecular Diagnostics Market - Market Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global molecular diagnostics market was valued at US$ 6,077.9 Mn in 2016, and is expected to reach US$ 12,358.6 Mn by 2025 expanding at a CAGR of 7.8% from 2017 to 2025.

Market Insights

Molecular diagnostics has undergone tremendous technological advancement due to the growing need for personalized medication, rapid diagnosis to determine antibiotic regimen in order to prevent drug resistance and for the in-depth study of pandemic diseases such as Cholera, Swine flu, Dengue and Hepatitis A. In 2016, the reagents and kits held the largest revenue share for the product segment due to factors such as increasing number of clinics and laboratories performing diagnosis, rising public awareness leading to early disease diagnosis and treatment, and government initiatives to promote public health and welfare. Instruments will be the fastest growing segment among the considered products throughout the forecast period 2017-2025 as they are undergoing tremendous modifications corresponding to specific requirements and inbuilt applications make it easy for the skilled workforce to perform accurate diagnosis in lesser span of time.

Infectious disease diagnostics is the leading the segment among the application areas due to factors such as increasing number of infectious disease, and growing demand for infectious disease diagnosis in tropical countries as the weather favors the microbes and vectors transmitting such diseases. Oncology will be the fastest growing segment in the application market through the forecast period 2017-2025, majorly due to factors such as rising prevalence of cancer, increasing demand for pharmacogenomics and technological advancement in the molecular diagnostic devices. Polymerase chain reaction holds the largest market in the technology segment for the base year 2016 due to factors such as its potential to detect rare diseases, rising demand for personalized medication and pharmacogenomics, and its potential in establishing the DNA sequence of patients, which will be helpful in the prevention of several life threatening diseases. Microarray will be the fastest growing technology segment throughout the forecast period 2017-2025 as it is helpful in diagnosing different types of cancer on the basis of the genetic pattern and increasing demand for toxicogenomics, which helps in determining the antibiotics of choice in cases of multiple drug resistance.

The global molecular diagnostics market is technologically driven and includes major players such as Abbott Laboratories, Inc., Novartis AG, Alere, Inc., Siemens Healthcare, Bayer AG, and F.Hoffman La Roche Ltd. etc. are few market leaders in molecular diagnostic market and compete to augment their foothold in the market.

Key Market Movements:
  • Rising prevalence of patients suffering with critical illnesses requiring immediate diagnosis
  • Increase in the number of research and academic institutes utilizing diagnostic reagents and instruments
  • Technological advancement in the nature of diagnostic reagents and kits providing better results
  • Affordable reimbursement scenario
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer AG
  • BioMerieux SA
  • Danaher Corporation
  • F.Hoffman La-Roche Ltd.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Molecular Diagnostics Market Portraiture
2.1.1. Global Molecular Diagnostics Market, by Product, 2016
2.1.2. Global Molecular Diagnostics Market, by Technology, 2016
2.1.3. Global Molecular Diagnostics Market, by Application, 2016
2.1.4. Global Molecular Diagnostics Market, by Geography, 2016

Chapter 3. Molecular Diagnostics Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases (Cholera, Malaria, Coronary Artery Disease, Diabetes, ESRD, & Chronic Kidney Diseases etc.)
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Molecular Diagnostics Market, by Product
4.3. Reagents and Kits
4.4. Instruments
4.5. Services and Software

Chapter 5. Global Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Molecular Diagnostics Market, by Technology
5.2. Polymerase Chain Reaction
5.3. Isothermal Nucleic Acid Amplification Technology
5.4. Insitu Hybridization
5.5. Microarray
5.6. Others

Chapter 6. Global Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Molecular Diagnostics Market, by Application
6.2. Infectious Disease
6.3. Oncology
6.4. Next Generation Sequencing
6.5. DNA Sequencing
6.6. Microbiology
6.7. Others

Chapter 7. Global Molecular Diagnostics Market, by Geography, 2015 - 2025 (US$ Mn)
7.1. Overview
7.2. North America Molecular Diagnostics Market Analysis, 2015 - 2025
7.2.1. North America Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
7.2.2. North America Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
7.2.3. North America Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
7.2.4. North America Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Molecular Diagnostics Market Analysis, 2015 - 2025
7.3.1. Europe Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
7.3.2. Europe Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
7.3.3. Europe Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
7.3.4. Europe Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Molecular Diagnostics Market Analysis, 2015 - 2025
7.4.1. Asia Pacific Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
7.4.2. Asia Pacific Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
7.4.3. Asia Pacific Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
7.4.4. Asia Pacific Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Molecular Diagnostics Market Analysis, 2015 - 2025
7.5.1. Latin America Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
7.5.2. Latin America Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
7.5.3. Latin America Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
7.5.4. Latin America Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Molecular Diagnostics Market Analysis, 2015 - 2025
7.6.1. MEA Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
7.6.2. MEA Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
7.6.3. MEA Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
7.6.4. MEA Molecular Diagnostics Market, by Region, 2015 - 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Alere, Inc.
8.3. Bayer AG
8.4. Becton Dickinson and Company
8.5. BioMerieux SA
8.6. Bio-Rad Laboratories, Inc.
8.7. Danaher Corporation
8.8. F.Hoffman La-Roche Ltd.
8.9. Novartis AG
8.10. Qiagen N.V.
8.11. Siemens Healthcare
8.12. Sysmex Corporation

List of Figures
Fig. 1 Molecular Diagnostics: Market Segmentation
Fig. 2 Global Molecular Diagnostics Market Share, by Product, 2016 (Value %)
Fig. 3 Global Molecular Diagnostics Market Share, by Technology, 2016 (Value %)
Fig. 4 Global Molecular Diagnostics Market, by Application, 2016 (US$ Mn)
Fig. 5 Global Molecular Diagnostics Market Share, by Geography, 2016 (Value %)
Fig. 6 Attractive Investment Proposition, by Geography
Fig. 7 Market Competition Landscape, by Key Players, 2016
Fig. 8 Global Reagents and Kits Market by Product, 2015 - 2025 (US$ Mn)
Fig. 9 Global Instruments Market by Product, 2015 - 2025 (US$ Mn)
Fig. 10 Global Services and Software Market by Product, 2015 - 2025 (US$ Mn)
Fig. 11 Global Polymerase Chain Reaction Market by Technology, 2015 - 2025 (US$ Mn)
Fig. 12 Global INAAT Market by Technology, 2015 - 2025 (US$ Mn)
Fig. 13 Global Insitu Hybridization Market by Technology, 2015 - 2025 (US$ Mn)
Fig. 14 Global Microarray Market by Technology, 2015 - 2025 (US$ Mn)
Fig. 15 Global Others Molecular Diagnostics Market by Technology, 2015 - 2025 (US$ Mn)
Fig. 16 Global Infectious Disease Market by Application, 2015 - 2025 (US$ Mn)
Fig. 17 Global Oncology Market by Application, 2015 - 2025 (US$ Mn)
Fig. 18 Global Next Generation Sequencing Market by Application, 2015 - 2025 (US$ Mn)
Fig. 19 Global DNA Sequencing Market by Application, 2015 - 2025 (US$ Mn)
Fig. 20 Global Microbiology Market by Application, 2015 - 2025 (US$ Mn)
Fig. 21 Global Others Molecular Diagnostics Market by Application, 2015 - 2025 (US$ Mn)
Fig. 22 U.S. Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 23 Canada Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 24 U.K. Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 25 Germany Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 26 France Molecular Diagnostics Market, 2015-2025 (US$ Mn)
Fig. 27 Rest of Europe Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 28 Japan Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 29 China Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 30 India Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 31 Rest of Asia Pacific Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 32 Brazil Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 33 Mexico Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 34 Rest of Latin America Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 35 GCC Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 36 Rest of Middle East and Africa Molecular Diagnostics Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
Table 2 Global Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
Table 3 Global Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
Table 4 Global Molecular Diagnostics Market, by Geography, 2015 - 2025 (US$ Mn)
Table 5 North America Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
Table 6 North America Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
Table 7 North America Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
Table 8 North America Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Europe Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
Table 10 Europe Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
Table 11 Europe Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
Table 12 Europe Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Asia Pacific Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
Table 14 Asia Pacific Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
Table 15 Asia Pacific Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
Table 16 Asia Pacific Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
Table 17 Latin America Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
Table 18 Latin America Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
Table 19 Latin America Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
Table 20 Latin America Molecular Diagnostics Market, by Country, 2015 - 2025 (US$ Mn)
Table 21 Middle East and Africa Molecular Diagnostics Market, by Product, 2015 - 2025 (US$ Mn)
Table 22 Middle East and Africa Molecular Diagnostics Market, by Technology, 2015 - 2025 (US$ Mn)
Table 23 Middle East and Africa Molecular Diagnostics Market, by Application, 2015 - 2025 (US$ Mn)
Table 24 Middle East and Africa Molecular Diagnostics Market, by Region, 2015 - 2025 (US$ Mn)
Table 25 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 26 Alere, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 27 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 28 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 29 BioMerieux SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 30 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 31 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 32 F.Hoffman La-Roche Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 33 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 34 Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 35 Siemens Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 36 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer AG
  • Becton Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F.Hoffman La-Roche Ltd.
  • Novartis AG
  • Qiagen N.V.
  • Siemens Healthcare
  • Sysmex Corporat
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll